![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Rothenburger, Tamara; Thomas, Dominique; Schreiber, Yannick; Wratil, Paul R.; Pflantz, Tamara; Knecht, Kirsten; Digianantonio, Katie; Temple, Joshua; Schneider, Constanze; Baldauf, Hanna-Mari; McLaughlin, Katie-May; Rothweiler, Florian; Bilen, Berna; Farmand, Samira; Bojkova, Denisa; Costa, Rui; Ferreiros, Nerea; Geisslinger, Gerd; Oellerich, Thomas; Xiong, Yong; Keppler, Oliver T.; Wass, Mark N.; Michaelis, Martin und Cinatl, Jindrich
(2021):
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.
In: Journal of Experimental & Clinical Cancer Research, Bd. 40, Nr. 1, 317
Rothenburger, Tamara; McLaughlin, Katie-May; Herold, Tobias; Schneider, Constanze; Oellerich, Thomas; Rothweiler, Florian; Feber, Andrew; Fenton, Tim R.; Wass, Mark N.; Keppler, Oliver T.; Michaelis, Martin und Cinatl, Jindrich
(2020):
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.
In: Communications Biology, Bd. 3, Nr. 1
Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; Knecht, Kirsten M.; Buzovetsky, Olga; Kaderali, Lars; Schliemann, Christoph; Bohnenberger, Hanibal; Angenendt, Linus; Hartmann, Wolfgang; Wardelmann, Eva; Rothenburger, Tamara; Mohr, Sebastian; Scheich, Sebastian; Comoglio, Federico; Wilke, Anne; Stroebel, Philipp; Serve, Hubert; Michaelis, Martin; Ferreiros, Nerea; Geisslinger, Gerd; Xiong, Yong; Keppler, Oliver T. und Cinatl, Jindrich
(2019):
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
In: Nature Communications, Bd. 10, 3475
[PDF, 2MB]
Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T. und Cinatl, Jindrich
(2017):
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
In: Nature Medicine, Bd. 23, Nr. 2: S. 250-255